The companies that will be represented are Acciona, BME, CIE Automotive, Ebro Foods, Hispania, Inmobiliaria Colonial, LAR España, Mediaset, Merlin Properties, Metrovacesa, Parques Reunidos, PharmaMar and Sacyr, which have a combined market value of €35 Billion.
Seventh edition of the “Spanish Small & Midcaps Conference”.
Tuesday, 12 June, marks the start of the seventh edition of the “Spanish Small & Midcaps Conference”, co-hosted by BME and JB Capital Markets in New York. The Conference will bring together the senior managers of 13 Spanish listed companies of medium and small capitalisation with over 40 US institutional investors interested in exploring opportunities in the Spanish market.
Through the more than 100 one-on-one meetings scheduled, top international investors will have the opportunity to meet Spanish companies in order to provide them with information for their investment decisions.
...
DESPUES DE 18 AÑOS CON SOLO TOPOTECAN CON FULL APPROVAL EN EEUU COMO TREATMENT 2a LÍNE SCLC-ES ... LA USFDA ACABA DE APROBAR AL TARLATAMAB CON FULL APPROVAL ... POR LO QUE ES YA EL NEW TREATMENT STÁNDARD EN EEUU . TIENE APROBACIÓNES ACELERADAS EN CANADA , UK, COREA ... Y EN DÍAS PODRÍA ALCANZAR LA APROBACIÓN TAMBIÉN EN CHINA QUE EN JULIO 2025, LA NMPA ACEPTÓ LA SOLICITUD DE REGISTRO (NDA) PARA TARLA OTORGÁNDOLE ADEMAS LA REVISIÓN PRIORITARIA . LA EMA TAMBIÉN LO ESTÁ YA EVALUANDO .
12 junio 2018
Zepsyre ( Lurbinectedin ) Focus - Small Cell Lung Cancer Virtual Roundtable .
In this clip the panel goes over newly released data concerning Lurbinectedin.
Description : H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on immunotherapy of a three part series dedicated to the advancements in treatment of small cell lung cancer.
The discussants include Anne Chiang MD, PhD, Associate Professor, Yale University School of Medicine, Deputy Chief Medical Officer, Chief Network Officer, Smilow Cancer Hospital, Taofeek Owonikoko, MD, PhD, MSCR, Professor, Department of Hematology & Medical Oncology, Emory University School of Medicine, Co-Chair, Clinical & Translational Review Committee, Winship Cancer Institute of Emory University, Jeff Petty, MD, Director, Thoracic Oncology Program, Professor of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine.
In this clip the panel goes over newly released information concerning immunotherapy for small cell lung cancer patients.
Description : H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on immunotherapy of a three part series dedicated to the advancements in treatment of small cell lung cancer.
The discussants include Anne Chiang MD, PhD, Associate Professor, Yale University School of Medicine, Deputy Chief Medical Officer, Chief Network Officer, Smilow Cancer Hospital, Taofeek Owonikoko, MD, PhD, MSCR, Professor, Department of Hematology & Medical Oncology, Emory University School of Medicine, Co-Chair, Clinical & Translational Review Committee, Winship Cancer Institute of Emory University, Jeff Petty, MD, Director, Thoracic Oncology Program, Professor of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine.
In this clip the panel goes over newly released information concerning immunotherapy for small cell lung cancer patients.
Suscribirse a:
Comentarios (Atom)



